GlassScriptPhysician profile
Joseph Campbell
NPI 1053351569
$1,046.05
in general payments reported to CMS, 2019-2025
12 companies · $73.37 in 2025
The $73.37 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $274 · 2021: $85.17 · 2022: $198 · 2023: $131 · 2024: $60.87 · 2025: $73.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $519.95 | 2019-2023 | |
| Biotronik INC. | $148.34 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.96 | 2019-2025 | Jardiance |
| Heartflow, INC. | $60.87 | 2024 | |
| Boston Scientific Corporation | $45.09 | 2019 | |
| Amgen INC. | $28.52 | 2019-2020 | |
| Cardiovascular Systems INC. | $28.01 | 2019 | |
| Pfizer INC. | $28.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.00 | 2025 | |
| Preventice Services, LLC | $18.46 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.47 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.38 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.